Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2021

View Archived Issues

Novel urotensin II receptor antagonists show efficacy in a mouse pressor response model

Novel thrombosis mouse models using Jak2 platelet conditional knockout

ShanghaiTech University patents ALK-targeting PROTACs

Medshine Discovery discloses new FGFR/VEGFR2 dual inhibitors

GlaxoSmithKline plc identifies new mTOR inhibitors

University of Alberta discovers ERCC1 inhibitors

U.S. researchers divulge new antibodies against C. difficile

B cell transcription factor helps gut regenerate

Axsome begins second pivotal study of AXS-05 in Alzheimer's disease agitation

Orca-T precision-engineered Treg grafts improve incidence of acute and chronic GvHD

AXS-07 provides durable migraine pain relief in phase III MOVEMENT trial

Patient dosing underway in phase Ib/II study of NP-137 for endometrial or cervix carcinoma

RedHill reports topline phase II data on opaganib in patients hospitalized with COVID-19 pneumonia

Investigators present new CRLF2-targeting antibody for Ph-like pediatric ALL

T-cell epitope-based COVID-19 vaccine EPV-CoV19 advances towards clinic

New humanized murine model of myelofibrosis shows therapeutic vulnerability

FDA clears IND for PBGM-01 for infantile GM1 gangliosidosis

HY-1702 found to be protective in LPS-induced respiratory distress syndrome in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...